Pathological and karyotypic abnormalities in advanced gastric carcinomas

Cancer Genetics and Cytogenetics

Volumn 109, Issue 1, 1999, Pages 45-50

  Espinoza, Luis A ^a   Neto, José Barbieri ^a   Casartelli, Cacilda ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHROMOSOME 3; CHROMOSOME 7; CHROMOSOME 9; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CYTOGENETICS; DIGESTIVE SYSTEM CANCER; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; KARYOTYPE; MALE; PRIORITY JOURNAL; STOMACH CANCER;

ADULT; AGED; CELL DIVISION; CHROMOSOME ABERRATIONS; CHROMOSOME BANDING; CHROMOSOME DISORDERS; FEMALE; HUMANS; KARYOTYPING; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; NEOPLASM STAGING; SEX CHROMOSOME ABERRATIONS; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED; X CHROMOSOME; Y CHROMOSOME;

EID: 0033080741     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(98)00149-6     Document Type: Article

References (35)

1. Borman R (1926): Gushwülste des magens und duodenums. In: Handbuch der Speziellen Pathologischen Anatomie und Histologie V. Henke-Lubrash. Bd. IV,1. Springer, Berlin.
2. Lauren T. The two histologic main types of gastric carcinomas. Acta Pathol Microbiol Scand. 64:1965;31-49.
3. TNM (1995): Classification of Malignant Tumors. 4th Ed. P. Hermanek, LH Sobin, eds. Springer-Verlag, Berlin.
4. Ferti-Passantonopoulou A., Panani A.D., Vlachos J.D., Raptis S.A. Common cytogenetic findings in gastric cancer. Cancer Genet Cytogenet. 24:1987;63-73.
5. Ochi H., Douglass H.O. Jr., Sandberg A.A. Cytogenetic studies in primary cancer. Cancer Genet Cytogenet. 22:1986;295-307.
6. Tzeng Ch-Ch Meng Ch-L., Jin L., Hsieh H.-F. Cytogenetic studies of gastric adenocarcinoma. Cancer Genet Cytogenet. 55:1991;67-71.
7. Xiao S., Geng J.-S., Feng X.L., Lui X.Q., Lui Q.Z., Li P. Cytogenetic studies of eight primary gastric cancers. Cancer Genet Cytogenet. 24:1987;63-73.
8. Castedo S., Correia C., David L., Sobrinho-Simũes M. Isochromosome 8q. a recurrent change in gastric carcinoma Cancer Genet Cytogenet. 54:1991;137-138.
9. Seruca R., Castedo S., Correia C., Gomes P., Carneiro F., Soares P., DeJong B., Sobrinho-Simũes M. Cytogenetic findings in eleven gastric carcinomas. Cancer Genet Cytogenet. 68:1993;42-48.
10. Yadavi M., Hopwood V.L., Multani A.S., Mansfield P.F., Takahashi Y., Mcintyre B.W., Udagawa T., Pathak S. Nonrandom primary and secondary chromosomal abnormalities in human gastric cancers. Anticancer Res. 16:1996;1787-1796.
11. Castedo S., Correia C., Gomes P., Seruca R., Soares P., Carneiro F., Sobrinho-Simũes M. Loss of Y chromosome in gastric carcinoma. Fact or artifact? Cancer Genet Cytogenet. 61:1992;39-41.
12. Rodriguez E., Rao P.H., Ladanyi M., Altorki N., Albino A.P., Kelsen D.P., Jhanwar S.C., Chaganti R.S.K. 11p13-15 is a specific region of chromosomal rearrangement in gastric and esophageal adenocarcinoma. Cancer Res. 50:1990;6410-6416.
13. ISCN (1995): An International System for Human Cytogenetic Nomenclature. F. Mitelman, ed. S. Karger, Basel.
14. Sandberg A.A. Chromosomal abnormalities and related events in prostate cancer. Human Pathol. 23:1992;368-380.
15. Rao P.H., Mathew S., Kelsen D.P., Chaganti R.S.K. Cytogenetics of gastric and esophageal adenocarcinomas. 3q deletion as a possible primary chromosomal change. Cancer Genet Cytogenet. 81:1995;139-143.
16. Sandberg A.A. The Chromosomes in Human Cancer and Leukemia. 2:1990;Elsevier Science Inc, New York.
17. Johansson B., Heim S., Mandahl N., Mertens F., Mitelman F. Trisomy in noneoplastic cells. Genes Chromosom Cancer. 6:1993;199-205.
18. Dave B.J., Hopwood V.L., Spitz M.R., Pathak S. Sex chromosome abnormalities in lung cancer patients. Cancer Genet Cytogenet. 87:1996;24-28.
19. Arps S., Rodewald A., Schmaleberger B., Carl P., Bressel M., Kastendieck H. Cytogenetic survey of 32 cancers of the prostate. Cancer Genet Cytogenet. 66:1993;93-99.
20. Logan J.A., Seizenger B.R., Atkins L., Martuza R.L. Loss of the Y chromosome in meningiomas. a molecular genetic approach Cancer Genet Cytogenet. 45:1990;41-47.
21. Panani A.D., Ferti-Passantonopoulou A., Malliars S., Raptis S. Cytogenetic studies of 11 gastric adenocarcinomas. Cancer Genet Cytogenet. 81:1995;169-172.
22. Yokoyama S., Yamakawa K., Tsuchiya E., Murata S., Sakiyama S., Nakamura Y. Deletion mapping on the short arm of chromosome 3 in squamous cell carcinoma and adenocarcinoma of the lung. Cancer Res. 52:1992;873-877.
23. Sainsbury JRC, Farndon JR, Sherbet VG, Harris AL (1985) Epidermal-growth-factor receptors and oestrogen receptors in human breast cancer. Lancet i:364-366.
24. Pathak S., Strong L.C., Ferrell R.E., Trindade A. Familial renal cell carcinoma with a 3, 11 chromosome translocation limited to tumor cells. Science. 217:1982;939-941.
25. Pandis N., Jin Y., Limon J., Bardi G., Idvall I., Mandahl N., Mitelman F., Heim S. Interstitial deletion of the short arm of chromosome 3 as a primary chromosome abnormality in carcinomas of the breast. Genes Chromosom Cancer. 6:1993;151-155.
26. Babu V.R., Miles B.J., Cerny J.C., Weiss L., Van Dyke D.L. Cytogenetic study of four cancers of the prostate. Cancer Genet Cytogenet. 48:1990;83-87.
27. Cairns P., Shaw M.E., Knowles M.A. Initiation of bladder cancers may involve deletion of a tumour suppressor gene on chromosome 9. Oncogene. 8:1993;1083-1085.
28. Wada M., Yokota J., Mizoguchi H., Sugimura T., Terada M. Infrequent loss of chromosomal heterozygosity in human stomach cancer. Cancer Res. 48:1988;2988-2992.
29. Baker S.J., Preisinger A.C., Jessup J.M., Paraskeva C.H., Markowitz S., Willson J.K.V., Hamilton S., Vogelstein B. p53 gene mutations occurs in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res. 50:1990;7717-7722.
30. Nigro J.M., Baker S.S., Preisinger A.C., Jessup J.M., Hostetter R., Cleary K., Bigner S.H., Davidson N., Baylin S., Devilee P., Glover T., Collins F.S., Weston A., Modali R., Harris C.C., Vogelstein B. Mutations in the p53 gene occur in diverse human tumour type. Nature. 342:1989;705-708.
31. Finlay C.A., Hinds P.W., Levine A.J. The p53 protooncogene can act as a suppressor of transformation. Cell. 57:1989;1083-1093.
32. Matozaki T., Sakamoto Ch Matsuda K., Suzuki T., Konda Y., Nakano O., Wada K., Uchida T., Nishisaki H., Nagao M. Missense mutations and a deletion of the p53 gene in human gastric cancer. Biochem Biophys Res Commun. 182:1992;215-223.
33. Nicholson G.L. Tumor cell instability, diversification and progression to the metastatic phenotype. from oncogene to oncofetal expression Cancer Res. 47:1987;1473-1487.
34. Wright P.A., Williams G.T. Molecular biology and gastric carcinoma. Gut. 34:1993;145-147.
35. Stemmermann G., Heffelfinger S.C., Noffsinger A., Hui Y.Z., Miller M.A., Fenoglio-Preiser C.M. The molecular biology of esophageal gastric cancer and their precursors oncogenes, tumor suppressor genes and growth factors. Human Pathol. 25:1994;968-981.